期刊文献+

敲低SET7慢病毒载体的构建及对乳腺癌细胞生长的影响 被引量:1

Construction of a lentiviral vector of SET7 small-interfering RNA and its effect on growth of breast cancer cells
原文传递
导出
摘要 目的为了探讨组蛋白甲基转移酶SET7在乳腺癌发生发展中的功能,构建SET7基因的RNA干扰(RNAi)慢病毒表达载体,研究其对乳腺癌细胞ZR75-1生长的影响。方法根据人SET7的c DNA序列,设计SET7基因短发夹RNA(shRNA)引物,并克隆到p SIH-H1-Puro载体上,包装成慢病毒,感染人乳腺癌细胞ZR75-1,通过实时定量(real-time)PCR以及Western印迹检测干扰效果,并通过生长曲线研究敲低SET7对ZR75-1细胞生长的影响。结果 DNA测序结果表明,SET7 shRNA慢病毒表达载体构建成功。实时定量PCR和Western印迹结果显示,SET7 shRNA能有效抑制SET7基因的表达。生长曲线实验表明,敲低SET7可抑制人乳腺癌细胞ZR75-1的生长。结论成功构建了SET7 shRNA慢病毒表达载体,感染人乳腺癌细胞ZR75-1后,有效抑制了内源SET7基因的表达,敲低SET7能抑制ZR75-1细胞的生长,为进一步研究SET7在乳腺癌中的功能奠定了基础。 Objective To study the biological function of histone methyltransferase SET 7 in the development and pro-gression of breast cancer by constructing the lentiviral vector of SET 7 small-interfering RNA and investigating its effect on the growth of ZR75-1 breast cancer cells.Methods Based on human SET7 cDNA sequence, short hairpin RNA(shRNA) primers targeting SET7 were designed and cloned into the vector pSIH-H1-Puro.Lentivirus was obtained and infected with ZR75-1 breast cancer cells .Real-time PCR and Western blotting were performed to identify the lentivirus-mediated knockdown of SET7.Growth curves were used to study the effect of SET 7 knockdown on the growth of ZR 75-1 cells. Results DNA sequencing indicated that the SET 7 shRNA lentiviral vector was constructed successfully .Real-time PCR and Western blotting showed that SET7 shRNA could suppress SET7 gene expression, which could in turn markedly inhibit the growth of ZR75-1 cells.Conclusion The lentivirus-mediated SET7 shRNA is successfully constructed .Knocking down SET7 could suppress the growth of ZR75-1 cells.
出处 《军事医学》 CAS CSCD 北大核心 2016年第11期897-900,共4页 Military Medical Sciences
基金 国家自然科学基金资助项目(31071174)
关键词 SET7基因 慢病毒载体 RNA干扰 乳腺肿瘤 SET7 gene lentivirus vector RNA interference breast neoplasms
  • 相关文献

参考文献2

二级参考文献54

  • 1Vargo-Cogla J, Rosen JM. Modelling breast cancer: one size does not fit all[J]. Nat Rev Cancer ,2007,7(9) :659 -672.
  • 2Tubiana M, Koscielny S. The rationale for early diagnosis of cancer-the example of breast cancer [J] . Acta Oncol, 1999,38 (3 ) : 295 - 303.
  • 3Abba MC, Sun H, Hawkins KA, et al. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status [J] . Mol Cancer Res, 2007 ,5 (9) : 881 - 890.
  • 4Rhodes DR, Yu J ,Shanker K ,et al. A cancer microarray database and integrated data-mining platform neoplasia [J]. Oncogene, 2004,6(1):1-6.
  • 5Wise-Draper TM,Mintz-Cole RA,Morris TA,et al. Overexpression of the cellular DEK protein promotes epithelial transformation iii vitro and in vivo[J]. Cancer Res,2009,69(5) :1792 -1799.
  • 6Waldmann T, Scholten t, Kappes F, et al. The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin [J]. Gene,2004,343(1) :1-9.
  • 7Kappes F,Fahrer 1, Khodadoust MS,et al, DEK is a poly(ADPri bose ) acceptor in apoptosis and mediates resistance to genotoxic stress[J]. Mol Cell Biol,2008,28(1O) :3245 -3257.
  • 8Waldmann T, Baack M, Richter N ,et al. Structure-specific binding of the proto-oncogene protein DEK to DNA [J] . Nucleic Acids Res,2003 ,31 (23) :7003 -7010.
  • 9Waldmann T, Eckerich C, Baack M, et al. The ubiquitous chromate in protein DEK alters the structure of DNA by introducing positive supercoils [J] . J Bioi Chern, 2002 , 277 ( 28 ) : 24988 - 24994.
  • 10Larramendy ML, Niini T , Elonen E, et al. Overexpression of translocation-associated fusion genes of FGFRI, MYC NPMI, and DEK , but absence of the translocations in acute myeloid leukemia [J]. Haematologica,2002,87(6) :569 -577.

共引文献1

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部